Effects of iron supplementation on serum hepcidin and serum erythropoietin in low-birth-weight infants

American Journal of Clinical Nutrition

Volumn 94, Issue 6, 2011, Pages 1553-1561

  Berglund, Staffan ^a   Lönnerdal, Bo ^b   Westrup, Björn ^c   Domellöf, Magnus ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; FERRITIN; FERROUS SUCCINATE; HEMOGLOBIN; HEPCIDIN; PLACEBO; TRANSFERRIN RECEPTOR;

ARTICLE; CELL VOLUME; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FERRITIN BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HIGH RISK INFANT; HORMONE BLOOD LEVEL; HUMAN; INFANT; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON INTAKE; IRON THERAPY; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL;

ANEMIA, IRON-DEFICIENCY; ANTIMICROBIAL CATIONIC PEPTIDES; DIETARY SUPPLEMENTS; ERYTHROPOIETIN; FEMALE; FERRITINS; HEMOGLOBINS; HUMANS; INFANT; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; IRON; MALE; NUTRITIONAL STATUS; RECEPTORS, TRANSFERRIN; REFERENCE VALUES; TRACE ELEMENTS; TRANSFERRIN;

EID: 82355165163     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.111.013938     Document Type: Article

References (44)

1. World Health Organization. Iron deficiency anaemia: assessment, prevention and control. A guide for programme managers. Geneva, Switzerland: World Health Organization, 2001. Available from: http://www.who.int/nutrition/ publications/en/ida-assessment-prevention-control.pdf (cited 28 May 2009).
2. Edmond K, Bahl R. Optimal feeding of low-birth-weight infants. Geneva, Switzerland: World Health Organization, 2006. Available from: http://whqlibdoc.who.int/publications/2006/9789241595094-eng.pdf (cited 20 November 2008).
3. Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, Adermann K. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 2000;480:147-50.
4. Park CH, Valore EV,Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001;276(11):7806-10.
5. Nemeth E, Ganz T. The role of hepcidin in iron metabolism. Acta Haematol 2009;122:78-86.
6. Viatte L, Vaulont S. Hepcidin, the iron watcher. Biochimie 2009;91:1223-8.
7. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loreal O. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001;276:7811-9.
8. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306:2090-3. (Pubitemid 40007660)
9. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, Kahn A, Vaulont S. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002;110:1037-44.
10. Lee P, Peng H, Gelbart T, Wang L, Beutler E. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci USA 2005;102:1906-10. (Pubitemid 40261985)
11. Kemna E, Pickkers P, Nemeth E, van der Hoeven H, Swinkels D. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 2005;106:1864-6. (Pubitemid 41208606)
12. Frazer DM, Wilkins SJ, Becker EM, Vulpe CD, McKie AT, Trinder D, Anderson GJ. Hepcidin expression inversely correlates with the expression of duodenal iron transporters and iron absorption in rats. Gastroenterology 2002;123:835-44. (Pubitemid 34977090)
13. Li H, Ginzburg YZ. Crosstalk between iron metabolism and erythropoiesis. Adv Hematol 2010;2010:605435.
14. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, Vaulont S. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 2001;98:8780-5. (Pubitemid 32678104)
15. Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, Grandchamp B, Sirito M, Sawadogo M, Kahn A, Vaulont S. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci U S A 2002;99(7):4596-601. (Pubitemid 34286030)
16. Rivera S, Nemeth E, Gabayan V, Lopez MA, Farshidi D, Ganz T. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood 2005;106:2196-9. (Pubitemid 41291740)
17. Pinto JP, Ribeiro S, Pontes H, Thowfeequ S, Tosh D, Carvalho F, Porto G. Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha. Blood 2008;111:5727-33.
18. Huang H, Constante M, Layoun A, Santos MM. Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli. Blood 2009;113:3593-9.
19. Nemeth E. Hepcidin in beta-thalassemia. Ann N Y Acad Sci 2010;1202:31-5.
20. Iannotti LL, Tielsch JM, Black MM, Black RE. Iron supplementation in early childhood: health benefits and risks. Am J Clin Nutr 2006;84:1261-76. (Pubitemid 44912807)
21. Domellöf M. Benefits and harms of iron supplementation in iron-deficient and iron-sufficient children. Nestle Nutr Workshop Ser Pediatr Program 2010;65:153-62; discussion 162-5.
22. Domellöf M, Lonnerdal B, Abrams SA, Hernell O. Iron absorption in breast-fed infants: effects of age, iron status, iron supplements, and complementary foods. Am J Clin Nutr 2002;76:198-204. (Pubitemid 34686567)
23. Domellöf M, Cohen RJ, Dewey KG, Hernell O, Rivera LL, Lonnerdal B. Iron supplementation of breast-fed Honduran and Swedish infants from 4 to 9 months of age. J Pediatr 2001;138:679-87. (Pubitemid 32417668)
24. Lönnerdal B, Kelleher SL. Iron metabolism in infants and children. Food Nutr Bull 2007;28(suppl):S491-9. (Pubitemid 351149499)
25. Berglund S, Westrup B, Domellof M. Iron supplements reduce the risk of iron deficiency anemia in marginally low birth weight infants. Pediatrics 2010;126:e874-83.
26. Rustad P, Felding P, Lahti A, Petersen HP. Descriptive analytical data and consequences for calculation of common reference intervals in the Nordic Reference Interval Project 2000. Scand J Clin Lab Invest 2004;64:343-70.
27. Saarinen UM, Siimes MA. Developmental changes in red blood cell counts and indices of infants after exclusion of iron deficiency by laboratory criteria and continuous iron supplementation. J Pediatr 1978;92:412-6. (Pubitemid 8296491)
28. Domellöf M, Dewey KG, Lonnerdal B, Cohen RJ, Hernell O. The diagnostic criteria for iron deficiency in infants should be reevaluated. J Nutr 2002;132:3680-6. (Pubitemid 35435047)
29. Saarinen UM, Siimes MA. Developmental changes in serum iron, total iron-binding capacity, and transferrin saturation in infancy. J Pediatr 1977;91:875-7. (Pubitemid 8242145)
30. Saarinen UM, Siimes MA. Serum ferritin in assessment of iron nutrition in healthy infants. Acta Paediatr Scand 1978;67:745-51. (Pubitemid 9010052)
31. HentzeMW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: regulation of mammalian iron metabolism. Cell 2010;142:24-38.
32. Malyszko J, Malyszko JS, Mysliwiec M. Serum prohepcidin and hepcidin in hemodialyzed patients undergoing iron therapy. Kidney Blood Press Res 2009;32:235-8.
33. Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M. Immunoassay for human serum hepcidin. Blood 2008;112:4292-7.
34. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004;113:1271-6. (Pubitemid 39069926)
35. Zimmermann MB, Troesch B, Biebinger R, Egli I, Zeder C, Hurrell RF. Plasma hepcidin is a modest predictor of dietary iron bioavailability in humans, whereas oral iron loading, measured by stable-isotope appearance curves, increases plasma hepcidin. Am J Clin Nutr 2009;90:1280-7.
36. Rehu M, Punnonen K, Ostland V, Heinonen S, Westerman M, Pulkki K, Sankilampi U. Maternal serum hepcidin is low at term and independent of cord blood iron status. Eur J Haematol 2010;85:345-52.
37. Cherian S, Forbes DA, Cook AG, Sanfilippo FM, Kemna EH, Swinkels DW, Burgner DP. An insight into the relationships between hepcidin, anemia, infections and inflammatory cytokines in pediatric refugees: a cross-sectional study. PLoS ONE 2008;3:e4030.
38. Schulze KJ, Christian P, Ruczinski I, Ray AL, Nath A, Wu LS, Semba RD. Hepcidin and iron status among pregnant women in Bangladesh. Asia Pac J Clin Nutr 2008;17:451-6.
39. Lasocki S, Baron G, Driss F, Westerman M, Puy H, Boutron I, Beaumont C, Montravers P. Diagnostic accuracy of serum hepcidin for iron deficiency in critically ill patients with anemia. Intensive Care Med 2010;36:1044-8.
40. Haase VH. Hypoxic regulation of erythropoiesis and iron metabolism. Am J Physiol Renal Physiol 2010;299:F1-13.
41. Fried W. Erythropoietin and erythropoiesis. Exp Hematol 2009;37:1007-15.
42. Kling PJ, Roberts RA, Widness JA. Plasma transferrin receptor levels and indices of erythropoiesis and iron status in healthy term infants. J Pediatr Hematol Oncol 1998;20:309-14. (Pubitemid 28483336)
43. de Klerk G, Wilmink JM, Rosengarten PC, Vet RJ, Goudsmit R. Serum erythropoietin (ESF) titers in anemia of chronic renal failure. J Lab Clin Med 1982;100:720-34. (Pubitemid 13241044)
44. Nicolas G, Viatte L, Bennoun M, Beaumont C, Kahn A, Vaulont S. Hepcidin, a new iron regulatory peptide. Blood Cells Mol Dis 2002;29:327-35.